Cognitive disorders in diabetic patients

Alafuzoff, 2009, Beta-amyloid deposition in brains of subjects with diabetes, Neuropathol Appl Neurobiol, 35, 60, 10.1111/j.1365-2990.2008.00948.x Albert, 1995, Predictors of cognitive change in older persons: MacArthur studies of successful aging, Psychol Aging, 10, 578, 10.1037/0882-7974.10.4.578 Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 Amieva, 2005, The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study, Brain, 128, 1093, 10.1093/brain/awh451 Anderson, 2001, The prevalence of comorbid depression in adults with diabetes: a meta-analysis, Diabetes Care, 24, 1069, 10.2337/diacare.24.6.1069 Angevaren, 2008, Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment, Cochrane Database Syst Rev,, 10.1002/14651858.CD005381.pub3 Annweiler, 2011, Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study, Dement Geriatr Cogn Disord, 32, 273, 10.1159/000334944 Arvanitakis, 2006, Diabetes is related to cerebral infarction but not to AD pathology in older persons, Neurology, 67, 1960, 10.1212/01.wnl.0000247053.45483.4e Atiea, 1995, Neuropsychological function in older subjects with noninsulin-dependent diabetes mellitus, Diabetic Med, 12, 679, 10.1111/j.1464-5491.1995.tb00569.x Aung, 2012, Severe hypoglycaemia and late-life cognitive ability in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabet Med, 29, 328, 10.1111/j.1464-5491.2011.03505.x Awad, 2004, The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function, J Clin Exp Neuropsychol, 26, 1044, 10.1080/13803390490514875 Baldwin, 2002, Vascular basis of late-onset depressive disorder, Br J Psychiatry, 180, 157, 10.1192/bjp.180.2.157 Barberger-Gateau, 2002, Fish, meat, and risk of dementia: cohort study, BMJ, 325, 932, 10.1136/bmj.325.7370.932 Barzilay, 2011, Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies, Arch Intern Med, 171, 142, 10.1001/archinternmed.2010.502 Beaulieu, 2002, The basis of anisotropic water diffusion in the nervous system – a technical review, NMR Biomed, 15, 435, 10.1002/nbm.782 Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570 Beeri, 2005, Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology, J Gerontol A Biol Sci Med Sci, 60, 471, 10.1093/gerona/60.4.471 Benedict, 2011, Intranasal insulin as a therapeutic option in the treatment of cognitive impairments, Exp Gerontol, 46, 112, 10.1016/j.exger.2010.08.026 Berk-Planken, 2002, Atorvastatin, diabetic dyslipidemia, and cognitive functioning, Diabetes Care, 25, 1250, 10.2337/diacare.25.7.1250 Berry, 1997, Dietary fatty acids in the management of diabetes mellitus, Am J Clin Nutr, 66, 991S, 10.1093/ajcn/66.4.991S Biessels, 2009, Diabetes: hypoglycemia and dementia in type 2 diabetes: chick or egg?, Nat Rev Endocrinol, 5, 532, 10.1038/nrendo.2009.182 Biessels, 2010, Caffeine, diabetes, cognition, and dementia, J Alzheimers Dis, 20, S143, 10.3233/JAD-2010-091228 Biessels, 2009 Biessels, 2006, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol, 5, 64, 10.1016/S1474-4422(05)70284-2 Blair, 2005, APOE genotype and cognitive decline in a middle-aged cohort, Neurology, 64, 268, 10.1212/01.WNL.0000149643.91367.8A Brands, 2005, The effects of type 1 diabetes on cognitive performance: a meta-analysis, Diabetes Care, 28, 726, 10.2337/diacare.28.3.726 Brands, 2006, Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes, Diabetes, 55, 1800, 10.2337/db05-1226 Brands, 2007, A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus, J Int Neuropsychol Soc, 13, 288, 10.1017/S1355617707070312 Breteler, 1994, Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study, BMJ, 308, 1604, 10.1136/bmj.308.6944.1604 Brismar, 2007, Predictors of cognitive impairment in type 1 diabetes, Psychoneuroendocrinology, 32, 1041, 10.1016/j.psyneuen.2007.08.002 Brown, 2009, Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study, BMJ, 338, b2030, 10.1136/bmj.b2030 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Bruce, 2006, Vascular depression in older people with diabetes, Diabetologia, 49, 2828, 10.1007/s00125-006-0478-y Bruce, 2008, Predictors of cognitive decline in older individuals with diabetes, Diabetes Care, 31, 2103, 10.2337/dc08-0562 Bruce, 2009, Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study, Diabetologia, 52, 1808, 10.1007/s00125-009-1437-1 Bruehl, 2009, Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus, Brain Res, 1280, 186, 10.1016/j.brainres.2009.05.032 Bruehl, 2010, Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance, J Clin Exp Neuropsychol, 32, 487, 10.1080/13803390903224928 Brundel, 2010, Cerebral cortical thickness in patients with type 2 diabetes, J Neurol Sci, 299, 126, 10.1016/j.jns.2010.08.048 Caccamo, 2005, Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders, Neurobiol Aging, 26, 645, 10.1016/j.neurobiolaging.2004.06.013 Charlton, 2006, White matter damage on diffusion tensor imaging correlates with age-related cognitive decline, Neurology, 66, 217, 10.1212/01.wnl.0000194256.15247.83 Christman, 2010, Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample, Arch Clin Neuropsychol, 25, 49, 10.1093/arclin/acp091 Cohen, 1988 Colberg, 2008, Physical activity participation may offset some of the negative impact of diabetes on cognitive function, J Am Med Dir Assoc, 9, 434, 10.1016/j.jamda.2008.03.014 Cordonnier, 2007, Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting, Brain, 130, 1988, 10.1093/brain/awl387 Corrigan, 1987, Relationships between parts A and B of the Trail Making Test, J Clin Psychol, 43, 402, 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E Cosway, 2001, Cognitive function and information processing in type 2 diabetes, Diabet Med, 18, 803, 10.1046/j.1464-5491.2001.00577.x Cox, 2005, Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes, Diabetes Care, 28, 71, 10.2337/diacare.28.1.71 Craft, 2012, Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial, Arch Neurol, 69, 29, 10.1001/archneurol.2011.233 Cukierman, 2005, Cognitive decline and dementia in diabetes – systematic overview of prospective observational studies, Diabetologia, 48, 2460, 10.1007/s00125-005-0023-4 Cukierman-Yaffe, 2009, Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial, Diabetes Care, 32, 221, 10.2337/dc08-1153 DCCT Research Group, 1996, Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial, Ann Intern Med, 124, 379, 10.7326/0003-4819-124-4-199602150-00001 de Bresser, 2010, Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes, Dement Geriatr Cogn Disord, 30, 381, 10.1159/000321354 de Bresser, 2010, Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes, Diabetes Care, 33, 1309, 10.2337/dc09-1923 de Galan, 2009, Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) Trial, Diabetologia, 52, 2328, 10.1007/s00125-009-1484-7 de Groot, 2002, Periventricular cerebral white matter lesions predict rate of cognitive decline, Ann Neurol, 52, 335, 10.1002/ana.10294 Deary, 1996, Severe hypoglycaemia and cognitive impairment in diabetes, BMJ, 313, 767, 10.1136/bmj.313.7060.767 Deary, 1993, Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes, Diabetes, 42, 341, 10.2337/diab.42.2.341 Deelman, 1981 den Heijer, 2003, Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI, Diabetologia, 46, 1604, 10.1007/s00125-003-1235-0 Desmond, 1993, Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort, Arch Neurol, 50, 162, 10.1001/archneur.1993.00540020040015 Desrocher, 2004, Neurocognitive correlates of type 1 diabetes mellitus in childhood, Child Neuropsychol, 10, 36, 10.1076/chin.10.1.36.26241 Devore, 2009, Dietary fat intake and cognitive decline in women with type 2 diabetes, Diabetes Care, 32, 635, 10.2337/dc08-1741 Dey, 1997, Cognitive function in younger type II diabetes, Diabetes Care, 20, 32, 10.2337/diacare.20.1.32 Dik, 2007, Contribution of metabolic syndrome components to cognition in older individuals, Diabetes Care, 30, 2655, 10.2337/dc06-1190 Ding, 2010, Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetes, 59, 2883, 10.2337/db10-0752 Dore, 2009, Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study, Diabetologia, 52, 2551, 10.1007/s00125-009-1497-2 Edland, 2004, Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease, J Mol Neurosci, 23, 213, 10.1385/JMN:23:3:213 Edland, 2003, Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE), Neurosci Lett, 345, 21, 10.1016/S0304-3940(03)00488-9 Egede, 2002, Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling, Arch Intern Med, 162, 427, 10.1001/archinte.162.4.427 Elias, 1997, NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study, Diabetes Care, 20, 1388, 10.2337/diacare.20.9.1388 Euser, 2010, A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study, Diabetes, 59, 1601, 10.2337/db09-0568 Fazekas, 1987, MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging, Am J Roentgenol, 149, 351, 10.2214/ajr.149.2.351 Feart, 2009, Adherence to a Mediterranean diet, cognitive decline, and risk of dementia, JAMA, 302, 638, 10.1001/jama.2009.1146 Ferguson, 2003, Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia, Diabetes, 52, 149, 10.2337/diabetes.52.1.149 Feskens, 1994, Apolipoprotein e4 allele and cognitive decline in elderly men, BMJ, 309, 1202, 10.1136/bmj.309.6963.1202 Folstein, 1975, Mini-mental state. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 Fontbonne, 2001, Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study, Diabetes Care, 24, 366, 10.2337/diacare.24.2.366 Freitas, 2013, Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease, Alzheimer Dis Assoc Disord, 27, 37, 10.1097/WAD.0b013e3182420bfe Frolich, 1998, Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease, J Neural Transm, 105, 423, 10.1007/s007020050068 Fuh, 2007, Glucose tolerance status and cognitive impairment in early middle-aged women, Diabet Med, 24, 788, 10.1111/j.1464-5491.2007.02170.x Gasparini, 2003, Potential roles of insulin and IGF-1 in Alzheimer's disease, Trends Neurosci, 26, 404, 10.1016/S0166-2236(03)00163-2 Gispen, 2000, Cognition and synaptic plasticity in diabetes mellitus, Trends Neurosci, 23, 542, 10.1016/S0166-2236(00)01656-8 Gold, 2010, Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study, Dement Geriatr Cogn Disord, 30, 131, 10.1159/000318845 Gomez, 2012, Intranasal treatment of neurodegenerative diseases and stroke, Front Biosci (Schol Ed), 4, 74, 10.2741/s252 Gouw, 2011, Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations, J Neurol Neurosurg Psychiatry, 82, 126, 10.1136/jnnp.2009.204685 Greenberg, 2009, Cerebral microbleeds: a guide to detection and interpretation, Lancet Neurol, 8, 165, 10.1016/S1474-4422(09)70013-4 Gregg, 2000, Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group, Arch Intern Med, 160, 174, 10.1001/archinte.160.2.174 Grodstein, 2001, Type 2 diabetes and cognitive function in community-dwelling elderly women, Diabetes Care, 24, 1060, 10.2337/diacare.24.6.1060 Haan, 1999, The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons, JAMA, 282, 40, 10.1001/jama.282.1.40 Hamer, 2009, Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence, Psychol Med, 39, 3, 10.1017/S0033291708003681 Hassing, 2004, Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study, Age Ageing, 33, 355, 10.1093/ageing/afh100 Irie, 2008, Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study, Arch Neurol, 65, 89, 10.1001/archneurol.2007.29 Jacobson, 2002, Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?, Int Rev Neurobiol, 51, 455, 10.1016/S0074-7742(02)51013-8 Jacobson, 2007, Long-term effect of diabetes and its treatment on cognitive function, N Engl J Med, 356, 1842, 10.1056/NEJMoa066397 Jacobson, 2010, The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in type 1 diabetes based on an 18-year follow-up of the DCCT cohort, Diabet Med, 27, 15, 10.1111/j.1464-5491.2009.02885.x Jacobson, 2011, Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort, Diabetologia, 54, 245, 10.1007/s00125-010-1883-9 Jolivalt, 2008, Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin, J Neurosci Res, 86, 3265, 10.1002/jnr.21787 Jones, 2008, Studying connections in the living human brain with diffusion MRI, Cortex, 44, 936, 10.1016/j.cortex.2008.05.002 Jongen, 2008, Structural brain imaging in diabetes: a methodological perspective, Eur J Pharmacol, 585, 208, 10.1016/j.ejphar.2007.11.085 Kadoi, 2005, Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes, J Thorac Cardiovasc Surg, 129, 576, 10.1016/j.jtcvs.2004.07.012 Kalmijn, 1997, Dietary fat intake and the risk of incident dementia in the Rotterdam Study, Ann Neurol, 42, 776, 10.1002/ana.410420514 Kalmijn, 2000, Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia Aging Study, Arterioscler Thromb Vasc Biol, 20, 2255, 10.1161/01.ATV.20.10.2255 Kanaya, 2004, Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo Study cohort, Arch Intern Med, 164, 1327, 10.1001/archinte.164.12.1327 Katon, 2012, Association of depression with increased risk of dementia in patients with type 2 diabetes. The Diabetes and Aging Study, Arch Gen Psychiatry, 69, 410, 10.1001/archgenpsychiatry.2011.154 Kilander, 1997, Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohort of 70-year-old men, J Intern Med, 242, 313, 10.1046/j.1365-2796.1997.00196.x Kloppenborg, 2008, Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review, Eur J Pharmacol, 585, 97, 10.1016/j.ejphar.2008.02.049 Knopman, 2001, Cardiovascular risk factors and cognitive decline in middle-aged adults, Neurology, 56, 42, 10.1212/WNL.56.1.42 Kodl, 2008, Diffusion tensor imaging (DTI) identifies deficits in white matter microstructure in subjects with type 1 diabetes mellitus that correlate with reduced neurocognitive function, Diabetes, 57, 3083, 10.2337/db08-0724 Koekkoek, 2012, Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes – the ADDITION-Netherlands Study: a cluster-randomized trial, J Neurol Sci, 314, 71, 10.1016/j.jns.2011.10.028 Komulainen, 2007, Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women, Dement Geriatr Cogn Disord, 23, 29, 10.1159/000096636 Korf, 2007, Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study, Diabet Med, 24, 166, 10.1111/j.1464-5491.2007.02049.x Krabbe, 2007, Brain-derived neurotrophic factor (BDNF) and type 2 diabetes, Diabetologia, 50, 431, 10.1007/s00125-006-0537-4 Kramer, 2007, Longitudinal MRI and cognitive change in healthy elderly, Neuropsychology, 21, 412, 10.1037/0894-4105.21.4.412 Kumari, 2005, Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study, Neurology, 65, 1597, 10.1212/01.wnl.0000184521.80820.e4 Launer, 1999, Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia, Neurology, 52, 78, 10.1212/WNL.52.1.78 Launer, 2011, Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy, Lancet Neurol, 10, 969, 10.1016/S1474-4422(11)70188-0 Lawson, 1984, Neuropsychological function in diabetic patients with neuropathy, Br J Psychiatry, 145, 263, 10.1192/bjp.145.3.263 Lehmann, 2005, Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease, Am J Epidemiol, 162, 305, 10.1093/aje/kwi202 Lezak, 2004 Li, 2007, Common pathological processes in Alzheimer disease and type 2 diabetes: a review, Brain Res Rev, 56, 384, 10.1016/j.brainresrev.2007.09.001 Li, 2007, Alzheimer-like changes in rat models of spontaneous diabetes, Diabetes, 56, 1817, 10.2337/db07-0171 Ligthart, 2010, Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review, Vasc Health Risk Manag, 6, 775, 10.2147/VHRM.S7343 Lindeman, 2001, A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey, Diabetes Care, 24, 1567, 10.2337/diacare.24.9.1567 Lobnig, 2006, Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications, Diabet Med, 23, 32, 10.1111/j.1464-5491.2005.01716.x Longstreth, 1998, Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study, Arch Neurol, 55, 1217, 10.1001/archneur.55.9.1217 Lu, 2009, Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis, PLoS One, 4, e4144, 10.1371/journal.pone.0004144 Luchsinger, 2001, Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort, Am J Epidemiol, 154, 635, 10.1093/aje/154.7.635 Luchsinger, 2007, Relation of diabetes to mild cognitive impairment, Arch Neurol, 64, 570, 10.1001/archneur.64.4.570 Manolio, 1994, Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study, Stroke, 25, 318, 10.1161/01.STR.25.2.318 Manschot, 2007, Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes, Diabetologia, 50, 2388, 10.1007/s00125-007-0792-z Manschot, 2008, Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients, J Neurol Sci, 264, 157, 10.1016/j.jns.2007.08.011 McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 Middleton, 2010, Targets for the prevention of dementia, J Alzheimers Dis, 20, 915, 10.3233/JAD-2010-091657 Mitchell, 2010, Screening and case finding tools for the detection of dementia. Part I: evidence-based meta-analysis of multidomain tests, Am J Geriatr Psychiatry, 18, 759, 10.1097/JGP.0b013e3181cdecb8 Muller, 2007, Metabolic syndrome and dementia risk in a multiethnic elderly cohort, Dement Geriatr Cogn Disord, 24, 185, 10.1159/000105927 Naor, 1997, Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control, J Diabetes Complications, 11, 40, 10.1016/1056-8727(95)00106-9 Nelson, 2008, Human cerebral neuropathology of type 2 diabetes mellitus, Biochim Biophys Acta, 1792, 454, 10.1016/j.bbadis.2008.08.005 Northam, 2006, Therapy insight: the impact of type 1 diabetes on brain development and function, Nat Clin Pract Neurol, 2, 78, 10.1038/ncpneuro0097 Nouwen, 2010, Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis, Diabetologia, 53, 2480, 10.1007/s00125-010-1874-x Okura, 2009, Association between cognitive function and social support with glycemic control in adults with diabetes mellitus, J Am Geriatr Soc, 57, 1816, 10.1111/j.1532-5415.2009.02431.x Ott, 1999, Diabetes mellitus and the risk of dementia: the Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937 Pan, 2010, Bidirectional association between depression and type 2 diabetes mellitus in women, Arch Intern Med, 170, 1884, 10.1001/archinternmed.2010.356 Pantoni, 2010, Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges, Lancet Neurol, 9, 689, 10.1016/S1474-4422(10)70104-6 Paranthaman, 2010, Vascular function in older adults with depressive disorder, Biol Psychiatry, 68, 133, 10.1016/j.biopsych.2010.04.017 Peila, 2002, Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study, Diabetes, 51, 1256, 10.2337/diabetes.51.4.1256 Petersen, 2001, Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 56, 1133, 10.1212/WNL.56.9.1133 Petersen, 2010, Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization, Neurology, 74, 201, 10.1212/WNL.0b013e3181cb3e25 Profenno, 2009, Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders, Biol Psychiatry, 67, 505, 10.1016/j.biopsych.2009.02.013 Qiu, 2006, Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis, Neurobiol Aging, 27, 190, 10.1016/j.neurobiolaging.2005.01.004 Qiu, 2001, The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen project, Arch Neurol, 58, 2034, 10.1001/archneur.58.12.2034 Raffaitin, 2011, Metabolic syndrome and cognitive decline in French elders: the Three-City Study, Neurology, 76, 518, 10.1212/WNL.0b013e31820b7656 Reaven, 1990, Relationship between hyperglycemia and cognitive function in older NIDDM patients, Diabetes Care, 13, 16, 10.2337/diacare.13.1.16 Reger, 2008, Intranasal insulin improves cognition and modulates beta-amyloid in early AD, Neurology, 70, 440, 10.1212/01.WNL.0000265401.62434.36 Reijmer, 2010, Cognitive dysfunction in patients with type 2 diabetes, Diabetes Metab Res Rev, 26, 507, 10.1002/dmrr.1112 Reijmer, 2011, Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors, Diabetes Metab Res Rev, 27, 195, 10.1002/dmrr.1163 Risner, 2006, Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease, Pharmacogenomics J, 6, 246, 10.1038/sj.tpj.6500369 Ritchie, 2001, Classification criteria for mild cognitive impairment: a population-based validation study, Neurology, 56, 37, 10.1212/WNL.56.1.37 Rossor, 2010, The diagnosis of young-onset dementia, Lancet Neurol, 9, 793, 10.1016/S1474-4422(10)70159-9 Ruis, 2009, Cognition in the early stage of type 2 diabetes, Diabetes Care, 32, 1261, 10.2337/dc08-2143 Ryan, 2006, Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis, Pediatr Diabetes, 7, 289, 10.1111/j.1399-5448.2006.00206.x Ryan, 1992, Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus, Diabetes, 41, 107, 10.2337/diab.41.1.107 Ryan, 2003, Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications, Diabetologia, 46, 940, 10.1007/s00125-003-1128-2 Ryan, 2006, Improving metabolic control leads to better working memory in adults with type 2 diabetes, Diabetes Care, 29, 345, 10.2337/diacare.29.02.06.dc05-1626 Sachon, 1992, Cognitive function, insulin-dependent diabetes and hypoglycaemia, J Intern Med, 231, 471, 10.1111/j.1365-2796.1992.tb00962.x Savva, 2009, Age, neuropathology, and dementia, N Engl J Med, 360, 2302, 10.1056/NEJMoa0806142 Scarmeas, 2006, Mediterranean diet, Alzheimer disease, and vascular mediation, Arch Neurol, 63, 1709, 10.1001/archneur.63.12.noc60109 Scarmeas, 2009, Mediterranean diet and mild cognitive impairment, Arch Neurol, 66, 216 Scharre, 2010, Self-administered Gerocognitive Examination (SAGE): a brief cognitive assessment instrument for mild cognitive impairment (MCI) and early dementia, Alzheimer Dis Assoc Disord, 24, 64, 10.1097/WAD.0b013e3181b03277 Scheltens, 1993, A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging, J Neurol Sci, 114, 7, 10.1016/0022-510X(93)90041-V Scheltens, 1997, Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging, Eur Neurol, 37, 95, 10.1159/000117417 Schramm, 2008, Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people, Circulation, 117, 1945, 10.1161/CIRCULATIONAHA.107.720847 Scott, 1998, The association of noninsulin-dependent diabetes mellitus and cognitive function in an older cohort, J Am Geriatr Soc, 46, 1217, 10.1111/j.1532-5415.1998.tb04536.x Sinclair, 2000, Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study, Diabetes Res Clin Pract, 50, 203, 10.1016/S0168-8227(00)00195-9 Smith, 2010, Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials, Psychosom Med, 72, 239, 10.1097/PSY.0b013e3181d14633 Sofi, 2011, Physical activity and risk of cognitive decline: a meta-analysis of prospective studies, J Intern Med, 269, 107, 10.1111/j.1365-2796.2010.02281.x Solfrizzi, 2004, Vascular risk factors, incidence of MCI, and rates of progression to dementia, Neurology, 63, 1882, 10.1212/01.WNL.0000144281.38555.E3 Stein, 2011, A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease, J Alzheimers Dis, 26, 477, 10.3233/JAD-2011-110149 Stroop, 1935, Studies of interference in serial verbal reactions, J Exp Psychol, 18, 643, 10.1037/h0054651 Tuokko, 2003, Five-year follow-up of cognitive impairment with no dementia, Arch Neurol, 60, 577, 10.1001/archneur.60.4.577 UK Hypoglycaemia Study Group, 2007, Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration, Diabetologia, 50, 1140, 10.1007/s00125-007-0599-y Umegaki, 2008, Factors associated with lower Mini Mental State Examination scores in elderly Japanese diabetes mellitus patients, Neurobiol Aging, 29, 1022, 10.1016/j.neurobiolaging.2007.02.004 U’Ren, 1990, The mental efficiency of the elderly person with type II diabetes mellitus, J Am Geriatr Soc, 38, 505, 10.1111/j.1532-5415.1990.tb02398.x van Boxtel, 1998, The relation between morbidity and cognitive performance in a normal aging population, J Gerontol A Biol Sci Med Sci, 53, M147, 10.1093/gerona/53A.2.M147 van de Pol, 2009 van den Berg, 2006, Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants, Drugs Today (Barc), 42, 741, 10.1358/dot.2006.42.11.1003542 van den Berg, 2008, Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn Study, Dement Geriatr Cogn Disord, 26, 261, 10.1159/000160959 van den Berg, 2009, Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition, Biochim Biophys Acta, 1792, 470, 10.1016/j.bbadis.2008.09.004 van den Berg, 2010, A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus, Diabetologia, 53, 58, 10.1007/s00125-009-1571-9 van Elderen, 2010, Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up, Neurology, 75, 997, 10.1212/WNL.0b013e3181f25f06 van Harten, 2006, Brain imaging in patients with diabetes: a systematic review, Diabetes Care, 29, 2539, 10.2337/dc06-1637 van Harten, 2007, Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus, Age Ageing, 36, 164, 10.1093/ageing/afl180 Vanhanen, 1997, Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function, NeuroReport, 8, 1527, 10.1097/00001756-199704140-00041 Vanhanen, 1998, Cognitive function in an elderly population with persistent impaired glucose tolerance, Diabetes Care, 21, 398, 10.2337/diacare.21.3.398 Vanhanen, 1999, Type-2 diabetes and cognitive function in a non-demented population, Acta Neurol Scand, 100, 97, 10.1111/j.1600-0404.1999.tb01045.x Vermeer, 2002, Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study, Stroke, 33, 21, 10.1161/hs0102.101629 Vermeer, 2007, Silent brain infarcts: a systematic review, Lancet Neurol, 6, 611, 10.1016/S1474-4422(07)70170-9 Wahlin, 2002, Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death, Neuropsychology, 16, 208, 10.1037/0894-4105.16.2.208 Watari, 2006, Cognitive function in adults with type 2 diabetes and major depression, Arch Clin Neuropsychol, 21, 787, 10.1016/j.acn.2006.06.014 Watson, 2005, Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study, Am J Geriatr Psychiatry, 13, 950 Wechsler, 1997 Weiner, 2008, Albuminuria, Cognitive Functioning, and White Matter Hyperintensities in Homebound Elders, Am J Kidney Dis, 53, 438, 10.1053/j.ajkd.2008.08.022 Werring, 2004, Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI, Brain, 127, 2265, 10.1093/brain/awh253 Wessels, 2007, Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume, Diabetologia, 50, 1763, 10.1007/s00125-007-0714-0 Whitmer, 2009, Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus, JAMA, 301, 1565, 10.1001/jama.2009.460 Whitwell, 2007, Patterns of atrophy differ among specific subtypes of mild cognitive impairment, Arch Neurol, 64, 1130, 10.1001/archneur.64.8.1130 Winblad, 2004, Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment, J Intern Med, 256, 240, 10.1111/j.1365-2796.2004.01380.x Wong, 2002, Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study, Stroke, 33, 1487, 10.1161/01.STR.0000016789.56668.43 Wong, 2003, Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people, Neurology, 61, 806, 10.1212/01.WNL.0000086372.05488.8D Wredling, 1990, Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man, Diabetologia, 33, 152, 10.1007/BF00404042 Xu, 2004, Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study, Neurology, 63, 1181, 10.1212/01.WNL.0000140291.86406.D1 Yaffe, 2004, Diabetes, impaired fasting glucose, and development of cognitive impairment in older women, Neurology, 63, 658, 10.1212/01.WNL.0000134666.64593.BA Yaffe, 2004, The metabolic syndrome, inflammation, and risk of cognitive decline, JAMA, 292, 2237, 10.1001/jama.292.18.2237 Yaffe, 2007, Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study, J Am Geriatr Soc, 55, 758, 10.1111/j.1532-5415.2007.01139.x Zhao, 2001, Role of insulin and insulin receptor in learning and memory, Mol Cell Endocrinol, 177, 125, 10.1016/S0303-7207(01)00455-5